finplate.co

finplate.co

Exploring the Most Impactful Biopharma Mergers and Acquisitions in 2023: A Comprehensive List of the Top 10 Deals

In 2023, the biopharma industry witnessed a resurgence in mergers and acquisitions, with the top 10 deals totaling $115.8 billion, led by Pfizer's $43 billion merger with Seagen, indicating renewed confidence despite the absence of monumental transactions like Bristol Myers Squibb's acquisition of Celgene or AbbVie's takeover of Allergan, with notable focus on antibody-drug conjugates (ADCs) and neuroscience, including BMS' $14 billion bid for Karuna Therapeutics and AbbVie's $8.7 billion takeover of Cerevel Therapeutics.

Powerful Partnership: Facility Solutions Group’s Acquisition of Greenleaf Energizes Solar Solutions for a Sustainable Future

Facility Solutions Group (FSG) acquires Greenleaf Energy Solutions, enhancing its national footprint in renewable energy with a focus on solar technologies, as former Greenleaf President Kevin Siebrecht leads FSG's Solar Division, aiming to expand services and provide turnkey solutions, reflecting FSG's commitment to sustainability and bolstering energy efficiency offerings for clients and employees alike.